Bjørn E Holstein1, Anette Andersen2, Anastasios Fotiou3, Inese Gobina4, Emmanuelle Godeau5, Ebba Holme Hansen6, Ron Iannotti7, Kate Levin8, Saoirse Nic Gabhainn9, Ulrike Ravens-Sieberer10, Raili Välimaa11. 1. 1 University of Southern Denmark, National Institute of Public Health, Copenhagen, Denmark bho@niph.dk. 2. 1 University of Southern Denmark, National Institute of Public Health, Copenhagen, Denmark. 3. 2 University Mental Health Research Institute, Athens, Greece. 4. 3 Department of Public Health and Epidemiology, Riga Stradins University, Riga, Latvia. 5. 4 French Institute of Health and Medical Research, Paris, France. 6. 5 Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark. 7. 6 Eunice Kennedy Shriver National Institute of Child Health and Human Development, Prevention Research Branch, Bethesda MD, USA. 8. 7 School of Medicine, Medical & Biological Sciences, University of St Andrews, St Andrews, Scotland. 9. 8 Health Promotion Research Centre, School of Health Sciences, National University of Ireland, Galway, Ireland. 10. 9 Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. 11. 10 Department of Health Sciences, University of Jyväskylä, Jyväskylän Yliopisto, Finland.
Abstract
BACKGROUND: This study reports secular trends in medicine use for headache among adolescents in 20 countries from 1986 to 2010. METHODS: The international Health Behaviour in School-aged Children (HBSC) survey includes self-reported data about medicine use for headaches among nationally representative samples of 11-, 13- and 15-year-olds. We included 20 countries with data from at least three data collection waves, with a total of 380 129 participants. RESULTS: The prevalence of medicine use for headaches varied from 16.5% among Hungarian boys in 1994 to 62.9% among girls in Wales in 1998. The prevalence was higher among girls than boys in every country and data collection year. The prevalence of medicine use for headaches increased in 12 of 20 countries, most notably in the Czech Republic, Poland, Russia, Sweden and Wales. CONCLUSION: The prevalence of medicine use for headaches among adolescents is high and increasing in many countries. As some medicines are toxic this may constitute a public health problem.
BACKGROUND: This study reports secular trends in medicine use for headache among adolescents in 20 countries from 1986 to 2010. METHODS: The international Health Behaviour in School-aged Children (HBSC) survey includes self-reported data about medicine use for headaches among nationally representative samples of 11-, 13- and 15-year-olds. We included 20 countries with data from at least three data collection waves, with a total of 380 129 participants. RESULTS: The prevalence of medicine use for headaches varied from 16.5% among Hungarian boys in 1994 to 62.9% among girls in Wales in 1998. The prevalence was higher among girls than boys in every country and data collection year. The prevalence of medicine use for headaches increased in 12 of 20 countries, most notably in the Czech Republic, Poland, Russia, Sweden and Wales. CONCLUSION: The prevalence of medicine use for headaches among adolescents is high and increasing in many countries. As some medicines are toxic this may constitute a public health problem.
Authors: F Centauri; A Pammolli; R Simi; P Dalmasso; P Berchialla; A Borraccino; L Charrier; M Lenzi; A Vieno; P Lemma; F Cavallo; G Lazzeri Journal: J Prev Med Hyg Date: 2019-12-20